PL372807A1 - Sposób wytwarzania kompozycji farmaceutycznej tworzącej samorzutnie emulsję drobnych cząstek - Google Patents

Sposób wytwarzania kompozycji farmaceutycznej tworzącej samorzutnie emulsję drobnych cząstek

Info

Publication number
PL372807A1
PL372807A1 PL03372807A PL37280703A PL372807A1 PL 372807 A1 PL372807 A1 PL 372807A1 PL 03372807 A PL03372807 A PL 03372807A PL 37280703 A PL37280703 A PL 37280703A PL 372807 A1 PL372807 A1 PL 372807A1
Authority
PL
Poland
Prior art keywords
preparing
pharmaceutical composition
pharmaceutically acceptable
composition
emulsifiable
Prior art date
Application number
PL03372807A
Other languages
English (en)
Inventor
Ping Gao
Xioarong He
Keith B. Bolyard
Original Assignee
Pharmacia Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corporation filed Critical Pharmacia Corporation
Publication of PL372807A1 publication Critical patent/PL372807A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
PL03372807A 2002-04-09 2003-04-07 Sposób wytwarzania kompozycji farmaceutycznej tworzącej samorzutnie emulsję drobnych cząstek PL372807A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37120002P 2002-04-09 2002-04-09

Publications (1)

Publication Number Publication Date
PL372807A1 true PL372807A1 (pl) 2005-08-08

Family

ID=29250656

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03372807A PL372807A1 (pl) 2002-04-09 2003-04-07 Sposób wytwarzania kompozycji farmaceutycznej tworzącej samorzutnie emulsję drobnych cząstek

Country Status (19)

Country Link
US (1) US20030235596A1 (pl)
EP (1) EP1492527B1 (pl)
JP (1) JP2005529104A (pl)
KR (1) KR100779285B1 (pl)
CN (1) CN1305470C (pl)
AT (1) ATE410162T1 (pl)
AU (1) AU2003223485B2 (pl)
BR (1) BR0309138A (pl)
CA (1) CA2481677A1 (pl)
DE (1) DE60323953D1 (pl)
ES (1) ES2310653T3 (pl)
HK (1) HK1076382A1 (pl)
IL (1) IL164163A0 (pl)
MX (1) MXPA04009880A (pl)
PL (1) PL372807A1 (pl)
RS (1) RS87004A (pl)
RU (1) RU2299061C2 (pl)
WO (1) WO2003086392A2 (pl)
ZA (1) ZA200407711B (pl)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10211801B4 (de) 2002-03-16 2004-09-30 Clariant Gmbh Kosmetische und pharmazeutische Zubereitungen enthaltend einen oxalkylierten Polyglycerinester
US9498454B2 (en) 2003-02-24 2016-11-22 Pharmaceutical Productions Inc. Transmucosal drug delivery system
US9254294B2 (en) 2003-02-24 2016-02-09 Pharmaceutical Productions Inc. Transmucosal hormone delivery system
US9358296B2 (en) 2003-02-24 2016-06-07 Pharmaceutical Productions Inc. Transmucosal drug delivery system
CA2516816C (en) * 2003-02-24 2012-02-07 Pharmaceutical Productions, Inc. Transmucosal drug delivery system
JP2006232755A (ja) * 2005-02-25 2006-09-07 Dai Ichi Kogyo Seiyaku Co Ltd 油中水型マイクロエマルション
US8293270B2 (en) 2005-10-26 2012-10-23 Banner Pharmacaps, Inc. Lipophilic vehicle-based dual controlled release matrix system
JP5406530B2 (ja) * 2005-10-26 2014-02-05 バナー ファーマキャプス， インコーポレイテッド 親水性ベヒクルに基づく二重制御された放出マトリクスシステム
MX2009010878A (es) * 2007-04-11 2010-03-26 John A Mccarty Pastilla de melatonina y metodos de preparacion y uso.
WO2011047259A1 (en) 2009-10-16 2011-04-21 Glaxosmithkline Llc Compositions
CA2785251A1 (en) * 2009-12-22 2011-06-30 Leo Pharma A/S Cutaneous composition comprising vitamin d analogue and a mixture of solvent and surfactants
AT13201U1 (de) 2011-01-28 2013-08-15 Blum Gmbh Julius Möbelteil mit einer drehmomentübertragenden Welle
US8951514B2 (en) 2011-02-16 2015-02-10 Pivotal Therapeutics Inc. Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels
US9119826B2 (en) 2011-02-16 2015-09-01 Pivotal Therapeutics, Inc. Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels
US8952000B2 (en) 2011-02-16 2015-02-10 Pivotal Therapeutics Inc. Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
JP6285866B2 (ja) 2011-11-23 2018-02-28 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 天然複合ホルモン補充製剤および療法
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
CN103965113A (zh) * 2014-05-06 2014-08-06 四川大学 1-羟乙基-2-取代苯氧甲基苯并咪唑类化合物及其制备方法
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
WO2015198350A1 (en) 2014-06-25 2015-12-30 Synergia Bio Sciences Private Limited A pharmaceutical oil-in-water nano-emulsion
US11400048B2 (en) 2014-06-25 2022-08-02 Synergia Bio Sciences Private Limited Pharmaceutical oil-in-water nano-emulsion
WO2016018993A1 (en) 2014-07-29 2016-02-04 Therapeuticsmd, Inc. Transdermal cream
MX2017015238A (es) 2015-05-28 2018-02-19 Dr Reddy´S Laboratories Ltd Composicion oral de celecoxib para tratamiento de dolor.
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
CN105343002B (zh) * 2015-11-27 2019-07-26 济南康和医药科技有限公司 一种依托考昔口服微乳制剂及其制备方法
BR112018070199A2 (pt) 2016-04-01 2019-01-29 Therapeuticsmd Inc composição farmacêutica de hormônio esteroide
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
CN111729125B (zh) * 2020-07-31 2022-10-04 陕西佰傲再生医学有限公司 骨止血材料
CA3144079A1 (en) * 2020-12-28 2022-06-28 Biodelivery Sciences International, Inc. Methods of treating pain
CN113750043A (zh) * 2021-09-18 2021-12-07 山东省药学科学院 一种塞来昔布自乳化口服液及其制备方法
KR102635930B1 (ko) 2021-10-29 2024-02-14 단국대학교 천안캠퍼스 산학협력단 자가나노유화 약물전달시스템을 이용한 셀레콕시브 함유 경구 투여용 제제 및 이의 제조방법
GB2616663A (en) * 2022-03-18 2023-09-20 Alkaloid Ad Skopje Pharmaceutical formulation

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7803330A (nl) * 1977-03-29 1978-10-03 Capsugel Ag Sluitcapsule gevuld met viskeus materiaal, in het bijzonder een vloeibaar farmaceutisch preparaat, en werkwijze voor het vervaardigen van een dergelijke capsule.
JP2564889B2 (ja) * 1988-03-07 1996-12-18 松下電工株式会社 軸流フアン
US5264223A (en) * 1990-03-29 1993-11-23 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US5466823A (en) * 1993-11-30 1995-11-14 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides
US5756123A (en) * 1994-12-01 1998-05-26 Japan Elanco Co., Ltd. Capsule shell
US5633272A (en) * 1995-02-13 1997-05-27 Talley; John J. Substituted isoxazoles for the treatment of inflammation
US5981576A (en) * 1995-10-13 1999-11-09 Merck Frosst Canada, Inc. (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors
US5993858A (en) * 1996-06-14 1999-11-30 Port Systems L.L.C. Method and formulation for increasing the bioavailability of poorly water-soluble drugs
US5861419A (en) * 1996-07-18 1999-01-19 Merck Frosst Canad, Inc. Substituted pyridines as selective cyclooxygenase-2 inhibitors
US6034256A (en) * 1997-04-21 2000-03-07 G.D. Searle & Co. Substituted benzopyran derivatives for the treatment of inflammation
EP1112060B1 (en) * 1998-09-09 2005-12-07 ALZA Corporation Dosage form comprising liquid formulation
AR035642A1 (es) * 2000-05-26 2004-06-23 Pharmacia Corp Uso de una composicion de celecoxib para el alivio rapido del dolor
TWI232761B (en) * 2000-07-01 2005-05-21 Pharmaceutical Ind Tech & Dev Capsule preparation for oral administration and the preparation method thereof
EP1299122A2 (en) * 2000-07-13 2003-04-09 Pharmacia Corporation Combination of a cox-2 inhibitor and a vasomodulator for treating pain and headache pain
US20030105141A1 (en) * 2001-04-17 2003-06-05 Ping Gao Finely self-emulsifiable pharmaceutical composition

Also Published As

Publication number Publication date
JP2005529104A (ja) 2005-09-29
CA2481677A1 (en) 2003-10-23
CN1658870A (zh) 2005-08-24
RS87004A (en) 2006-12-15
AU2003223485B2 (en) 2007-05-31
WO2003086392A3 (en) 2004-03-25
WO2003086392A2 (en) 2003-10-23
KR100779285B1 (ko) 2007-11-28
US20030235596A1 (en) 2003-12-25
CN1305470C (zh) 2007-03-21
AU2003223485A1 (en) 2003-10-27
KR20070014237A (ko) 2007-02-01
IL164163A0 (en) 2005-12-18
ES2310653T3 (es) 2009-01-16
HK1076382A1 (en) 2006-01-20
BR0309138A (pt) 2005-02-01
ZA200407711B (en) 2006-06-28
EP1492527B1 (en) 2008-10-08
MXPA04009880A (es) 2004-12-07
ATE410162T1 (de) 2008-10-15
EP1492527A2 (en) 2005-01-05
DE60323953D1 (de) 2008-11-20
RU2004130291A (ru) 2005-05-27
RU2299061C2 (ru) 2007-05-20

Similar Documents

Publication Publication Date Title
HK1076382A1 (en) Process for preparing a finely self-emulsifiable pharmaceutical composition
WO2002056878A3 (en) Pharmaceutical composition having reduced tendency for drug crystallization
CO5580835A2 (es) Nuevas formulaciones analogas de ciclosporina
NO20085078L (no) Nye forbindelser
EA200301019A1 (ru) Доставляемая перорально фармацевтическая композиция, включающая препарат с низкой растворимостью в воде (ингибитор cox-2), растворитель, жирную кислоту и органический амин
WO2005004917A3 (en) Pharmaceutical composition for solubility enhancement of hydrophobic drugs
BG106439A (en) Pharmaceutical composition of improved solubility and oral absorptivity, containing benzamide derivative
ATE409461T1 (de) Hfc lösungsformulierungen enthaltend ein anticholinergikum
WO2005065185A3 (en) Temperature-stable formulations, and methods of development thereof
ES2110377T1 (es) Formulacion galenica de fenofibrato y aplicacion de la misma.
DE602004011966D1 (en) Heterocyclylverbindungen
PL338335A1 (en) Pharmaceutic composition in the of self-emulsifiable formulation of lipophilic compounds
DK0734383T3 (da) Cykliske amidderivater som neurokinin-A-antagonister
SV2002000301A (es) Composicion farmaceutica ref. z-1032
DE60002755D1 (de) Benzothiadiazinderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
NO950134L (no) Formuleringer for oralt administrerte farmasöytiske midler
AU2408602A (en) Indole derivatives and use thereof in medicines
ATE293635T1 (de) Streptograminderivate, ihre herstellung und sie enthaltende zubereitungen
SE0002354D0 (sv) New formulation
IL164763A (en) Hyperforin derivatives, the use thereof and formulations containing them
KR940021524A (ko) 1,2,5,6-테트라하이드로피리딘 유도체와 이의 제조 방법 및 치료시 이의 이용방법
WO2021076847A1 (en) Compositions comprising quinone and/or quinol and methods of preparations and use thereof
WO2001053322A3 (en) Aerothricin analogs, their preparation and use
ATE252598T1 (de) Streptograminderivate, ihre herstellung und sie enthaltende zubereitungen
TH40972B (th) สารประกอบอินทรีย์

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)